Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 113400-36-5 | MDL No. : | MFCD04115781 |
Formula : | C17H21NO5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | TZNBTMCEMLXYEM-ZDUSSCGKSA-N |
M.W : | 319.35 | Pubchem ID : | 8027482 |
Synonyms : |
|
Num. heavy atoms : | 23 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.47 |
Num. rotatable bonds : | 7 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 87.37 |
TPSA : | 72.91 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.54 cm/s |
Log Po/w (iLOGP) : | 2.83 |
Log Po/w (XLOGP3) : | 2.41 |
Log Po/w (WLOGP) : | 2.12 |
Log Po/w (MLOGP) : | 1.83 |
Log Po/w (SILICOS-IT) : | 2.09 |
Consensus Log Po/w : | 2.26 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.07 |
Solubility : | 0.272 mg/ml ; 0.000852 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.58 |
Solubility : | 0.0834 mg/ml ; 0.000261 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.47 |
Solubility : | 0.107 mg/ml ; 0.000336 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.25 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73.8% | With dmap In dichloromethane at 0 - 20℃; | D-1 (8 g, 36.5 mmol, 1 eq) was dissolved in DCM (150 mL). The mixture was stirred and was cooled to 0° C. Dimethylaminopyridine (DMAP, 4.9 g, 40.1 mmol, 1.1 eq) was added followed by Boc-anhydride ((BOC)2O, 8.75 g, 40.1 mmol, 1.1 eq). The mixture was allowed to warm to room temperature and was stirred for 2 hours. The mixture was then diluted with DCM (250 mL) and was washed successively with aqueous HCl (1N, 50 mL), aqueous saturated bicarbonate solution (350 mL) and brine. The organic phase was dried over sodium sulfate, was concentrated under reduced pressure, and was purified by silica gel chromatography to provide D-2 (8.6 g, 73.8percent). LCMS (ES+, m/e=656, [2M+NH4+]). |
51.2 g | With dmap; triethylamine In dichloromethane at 20℃; for 16 h; Cooling with ice | Benzyl chloride (25.3ml, 0.22mol) was added to a solution of 5-oxo-l-proline (2) (25.8g, 0.20mol) with triethylamine (28.0ml, 0.20mol) in THF (260ml). The reaction mixture was refluxed at 70°C for 5days. After cooling the mixture to room temperature, the solvent was removed in vacuo. The residue was diluted with water, and extracted with chloroform. The organic layer was washed with brine, and dried over magnesium sulfate. The mixture was filtered, and the solvent was removed in vacuo to afford the crude product as pale brown oil. To a stirred solution of the product in dichloromethane (400ml) was added di-tert-butyl dicarbonate (44g, 0.20mol), triethylamine (28ml, 0.2mol) and DMAP (12.2g, 0.10mol) under an ice cooling bath. The solution was warmed to room temperature and stirred for 16h. The reaction mixture was diluted with water, and extracted with chloroform. The organic layer was washed with brine, and dried over magnesium sulfate. The mixture was filtered, and the solvent was removed in vacuo to afford crude product. The residue was purified by flash silica gel chromatography withn-hexane/EtOAc (2:1, v/v) to give the colorless solid (51.2g, 80percent yield);1H NMR (400MHz, CDCl3)δ: 1.42 (9H, s), 1.98–2.05 (1H, m), 2.26–2.37 (1H, m), 2.44–2.51 (1H, m), 2.57–2.66 (1H, m), 4.64 (1H, dd,J=9.5, 2.9Hz), 5.19 (1H, d,J=12.0Hz), 5.23 (1H, d,J=12.2Hz), 7.34–7.37 (5H, m); ESI/MS:m/z=342 (M+Na). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94.6% | With N-ethyl-N,N-diisopropylamine In toluene at 30 - 95℃; for 9 h; | To a 500 ml four-necked flask equipped with a stirrer, a thermometer and a reflux condenser was added 18.2 g (0.05 mol) of L-glutamic acid dibenzyl ester hydrochloride prepared in Example 1,150 g of toluene, 7.8 g (0.06 mol) of diisopropylethylamine,12.0 g (0.055 mol) di-tert-butyl dicarbonate, heated,30-35°C for 4 hours, 90-95°C for 5 hours,Cool to 2025°C, filter and distill the filtrate to recover the solvent.To the residue was added 50 g of methyl tert-butyl ether, recrystallized, filtered and dried.15.1 g of white powder solidN-tert-butyloxycarbonyl-L-pyroglutamic acid benzyl esterThe liquid phase purity was 99.9percent and the yield was 94.6percent. |
[ 32159-21-0 ]
(S)-1-((Benzyloxy)carbonyl)-5-oxopyrrolidine-2-carboxylic acid
Similarity: 0.93
[ 5211-23-4 ]
(S)-1-Benzyl 2-methyl pyrrolidine-1,2-dicarboxylate
Similarity: 0.89
[ 34897-61-5 ]
Dicyclohexylamine (S)-4-(((benzyloxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoate
Similarity: 0.88